Martina Schüssler-Lenz elected as new chair of Committee for Advanced Therapies
At its February meeting, the European Medicines Agency’s (EMA) Committee for Advanced Therapies (CAT) elected Dr Martina Schüssler-Lenz as its new chair, for a three-year mandate. She follows Paula-Anneli Salmikangas, who had chaired the Committee since February 2014.
#PharmaNews #EMA #EuropeanMedicinesAgency #MartinaSchüsslerLenz #CAT